Wells Fargo analyst Jeff Cantwell maintains Block (NYSE:SQ) with a Overweight and lowers the price target from $165 to $120.
Reported Late Monday, DURECT Corp. Announces 1-For-10 Reverse Stock Split
URECT Corporation (NASDAQ:DRRX), a biopharmaceutical company focused on developing epigenetic regulator programs for the treatment of acute organ injury and chronic liver diseases, announced that DURECT's board of
